RAFAEL HOLDINGS, INC. Retained Earnings
RAFAEL HOLDINGS, INC. (RFL) had Retained Earnings of -$252.72 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-06-11
- 2026-04-30: Retained Earnings (Accumulated Deficit) -$252.72M.
- 2026-01-31: Retained Earnings (Accumulated Deficit) -$248.50M.
- 2025-10-31: Retained Earnings (Accumulated Deficit) -$242.08M.
- 2025-07-31: Retained Earnings (Accumulated Deficit) -$232.26M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-04-30 | -$252.72M 10-Q · filed 2026-06-11 | |
| 2026-01-31 | -$248.50M 10-Q · filed 2026-03-16 | |
| 2025-10-31 | -$242.08M 10-Q · filed 2025-12-12 | |
| 2025-07-31 | -$232.26M 10-Q · filed 2026-06-11 | |
| 2025-04-30 | -$220.17M 10-Q · filed 2025-06-11 | |
| 2025-01-31 | -$215.39M 10-Q · filed 2025-03-14 | |
| 2024-10-31 | -$210.75M 10-Q · filed 2024-12-11 | |
| 2024-07-31 | -$201.74M 10-K · filed 2025-10-29 | |
| 2024-04-30 | -$197.28M 10-Q · filed 2024-06-14 | |
| 2024-01-31 | -$164.92M 10-Q · filed 2024-03-14 | |
| 2023-10-31 | -$170.97M 10-Q · filed 2023-12-14 | |
| 2023-07-31 | -$167.33M 10-Q · filed 2024-06-14 | |
| 2023-04-30 | -$168.55M 10-Q · filed 2023-06-13 | |
| 2023-01-31 | -$167.12M 10-Q · filed 2023-03-14 | |
| 2022-10-31 | -$163.87M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | -$165.46M 10-K · filed 2023-10-30 | |
| 2022-04-30 | -$160.67M 10-Q · filed 2022-06-14 | |
| 2022-01-31 | -$155.14M 10-Q · filed 2022-03-17 | |
| 2021-10-31 | -$152.82M 10-Q/A · filed 2022-02-28 | -$170.12M 10-Q · filed 2021-12-15 |
| 2021-07-31 | -$40.80M 10-K · filed 2022-10-31 | |
| 2021-04-30 | -$28.42M 10-Q · filed 2021-06-14 | |
| 2021-01-31 | -$25.87M 10-Q · filed 2021-03-17 | |
| 2020-10-31 | -$17.70M 10-Q · filed 2020-12-15 | |
| 2020-07-31 | -$16.25M 10-K · filed 2021-10-18 | |
| 2020-04-30 | -$10.85M 10-Q · filed 2020-06-09 | |
| 2020-01-31 | -$8.69M 10-Q · filed 2020-03-05 | |
| 2019-10-31 | -$7.44M 10-Q · filed 2019-12-09 | |
| 2019-07-31 | -$5.84M 10-K · filed 2020-10-29 | |
| 2019-04-30 | -$3.65M 10-Q · filed 2019-06-05 | |
| 2019-01-31 | -$2.65M 10-Q · filed 2019-03-12 | |
| 2018-10-31 | -$1.63M 10-Q · filed 2018-12-10 | |
| 2018-07-31 | -$1.11M 10-K · filed 2019-10-04 | |
| 2018-04-30 | -$192.00K 10-Q · filed 2018-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |